Extracellular cyclophilins contribute to the regulation of inflammatory responses

Journal of Immunology

Volumn 175, Issue 1, 2005, Pages 517-522

  Arora, Kamalpreet ^a   Gwinn, William M ^a   Bower, Molly A ^a   Watson, Alan ^a   Okwumabua, Ifeanyi ^a   MacDonald, H Robson ^b   Bukrinsky, Michael I ^a   Constant, Stephanie L ^a,c  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD147 ANTIGEN; CYCLOPHILIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; INFLAMMATION; MALE; MOUSE; NEUTROPHILIA; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

EID: 21244456368     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.1.517     Document Type: Article

References (22)

1. Sherry, B., N. Yartlett, A. Strupp, and A. Cerami. 1992. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide- activated macrophages. Proc. Natl. Acad. Sci. USA 89: 3511-3515.
2. Jin, Z. G., M. O. Melaragno, D. F. Liao, C. Van, J. Haendeler, Y. A. Suh, J. D. Lambeth, and B. C. Berk. 2000. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ. Res. 87: 789-796.
3. Seko, Y., T. Fujimura, H. Taka, R. Mineki, K. Murayama, and R. Nagai. 2004. Hypoxia followed by reoxygenation induces secretion of cyclophilin A from cultured rat cardiac myocytes. Biochem. Biophys. Res. Commun. 317: 162-168.
4. Tegeder, I., A. Schumacher, S. John, H. Geiger, G. Geisslinger, H. Bankg, and K. Brune. 1997. Elevated serum cyclophilin levels in patients with severe sepsis. J. Clin. Immunol. 17: 380-386.
5. Billich, A., G. Winkler, H. Aschauer, A. Rot, and P. Peichl. 1997. Presence of cyclophilin A in synovial fluids of patients with rheumatoid arthritis. J. Exp. Med. 185: 975-980.
6. Yurchenko, V., G. Zybarth, M. O'Connor, W. W. Dai, G. Franchin, T. Hao, H. Guo, H. C. Hung, B. Toole, P. Gallay, et al. 2002. Active-site residues of cyclophilin A are crucial for its signaling activity via CD147. J. Biol. Chem. 277: 22959-22965.
7. Xu, Q., M. C. Leiva, S. A. Fischkoff, R. E. Handschumacher, and C. R. Lytlle. 1992. Leukocyte chemotactic activity of cyclophilin. J. Biol. Chem. 267: 11968-11971.
8. Allain, F., C. Vanpouille, M. Carpentier, M. C. Slomianny, S. Durieux, and G. Spik. 2002. Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix. Proc. Natl. Acad. Sci. USA 99: 2714-2719.
9. Denys, A., F. Allain, M. Carpentier, and G. Spik. 1998. Involvement of two classes of binding sites in the interactions of cyclophilin B with peripheral blood T-lymphocytes. Biochem. J. 336: 689-697.
10. Saphire, A., M. Bobardt, and P. Gallay. 1999. Host cyclophilin A mediates HIV-1 attachment to target cells via heparans. EMBO J. 18: 6771-6785.
11. Bukrinsky, M. I. 2002. Cyclophilins: unexpected messengers in intercellular communications. Trends Immunol. 23: 323-325.
12. Karmpaliotis, D., I. Kosmidou, E. Ingenito, K. Hong, A. Malhotra, M. Sunday, and K. Haley. 2002. Angiogenic growth factors in the pathophysiology of a murine model of acute lung injury. Am. J. Physiol. 283: L585-L595.
13. Renno, T., A. Wilson, C. Dunkel, I. Coste, K. Maisnier-Patin, D. C. Benoit, J. P. Aubry, R. K. Lees, J. Y. Bonnefoy, H. R. MacDonald, et al. 2002. A role for CD147 in thymic development. J. Immunol. 168: 4946-4950.
14. Billich, A., F. Hammerschmid, P. Peichl, R. Wenger, G. Zenke, V. Quesniaux, and B. Rosenwirth. 1995. Mode of action of SDZNIM811, a nonimmunosuppresive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions. J. Virol. 69: 2451-2461.
15. Su, X., L. Wang, Y. Song, and C. Bai. 2004. Inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide. Intensive Care Med. 30: 133-140.
16. Konttinen, Y. T., T. F. Li, J, Mandelin, M. Liljestrom, T. Sorsa, S. Santavirta, and I. Virtanen. 2000. Increased expression of exracellular matrix metalloproteinase inducer in rheumatoid synovium. Arthritis Rheum. 43: 275-280.
17. Tomita, T., T. Nakase, M. Kaneko, K. Shi, K. Takahi, T. Ochi. and H. Yoshikawa. 2002. Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum. 46: 373-378.
18. Coste, I., J. Gauchat, A. Wilson, S. Izui, P. Jeannin, Y. Delneste, H. MacDonald, J. Bonnefoy, and T. Renno. 2001. Unavailability of CD147 leads to selective erythrocyte trapping in the spleen. Blood 15: 3984-3988.
19. Tessier, P., P. Naccache, I. dark-Lewis, and M. Baggiolini. 1997. Chemokine networks in vivo: involvement of both C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNFα. J. Immunol. 19: 3595-3602.
20. McColl, S. R., and I. Clark-Lewis. 1999. Inhibition of murine neutrophil recruitment in vivo by CXC chemokine receptor antagonists. J. Immunol. 163: 2829-2835.
21. Czermak, B., H. Friedl, and P. Ward. 1999. Role and regulation of chemokines in rodent models of lung inflammation. ILAR J. 40: 163-166.
22. Mukaida, N. 2003. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am. J. Physiol. 284: L566-L577.